Related references
Note: Only part of the references are listed.Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma
Rajni Sinha et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors
E. Cocorocchio et al.
HEMATOLOGICAL ONCOLOGY (2013)
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy
Diego Villa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
Ralph M. Meyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres
Stephen D. Smith et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging
Craig H. Moskowitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Andreas Engert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver
JC Lavoie et al.
BLOOD (2005)
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
A Sureda et al.
ANNALS OF ONCOLOGY (2005)
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
A Josting et al.
ANNALS OF ONCOLOGY (2005)
Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
T Baetz et al.
ANNALS OF ONCOLOGY (2003)
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
V Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Time-intensified dexamethasone/cisplatin/cytarabine:: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease
A Josting et al.
ANNALS OF ONCOLOGY (2002)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease:: a randomised trial
N Schmitz et al.
LANCET (2002)
Share Paper
